We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
BioNTech针对非小细胞肺癌的个性化mRNA疗法即将问世。该疫苗将黑色素瘤复发风险降低49%。了解个性化肿瘤学的未来。
